Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Muto

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
La Radiologia Medica|January 1, 1996
[High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience]A Gava, L Fontan, A Bolner, et al.
Cancer Research|May 15, 1998
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829I Virgolini, M Leimer, H Handmaker, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2001
Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancerR V Iaffaioli, A Tortoriello, A Gravina, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2017
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysisR Di Franco, V Borzillo, V Ravo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 6, 2026
Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted TherapyR Di Franco, D Pezzulla, V Borzillo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 7, 2026
Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084]R Di Franco, D Pezzulla, V Borzillo, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
La Radiologia Medica|January 1, 1996
[High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience]A Gava, L Fontan, A Bolner, et al.
Cancer Research|May 15, 1998
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829I Virgolini, M Leimer, H Handmaker, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2001
Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancerR V Iaffaioli, A Tortoriello, A Gravina, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2017
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysisR Di Franco, V Borzillo, V Ravo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 6, 2026
Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted TherapyR Di Franco, D Pezzulla, V Borzillo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 7, 2026
Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084]R Di Franco, D Pezzulla, V Borzillo, et al.
Pageof 6